What patterns are typical
Many patients describe their thinking as slightly slower or foggier in the first week. Some find concentration harder. Some report mild forgetfulness — names, why they walked into a room. These effects are usually mild and transient. Severe cognitive impairment is not typical and warrants prompt review.
Why it happens
Several contributors are at play. Sleep disruption affects cognition more than people realise — and disrupted sleep is common in the first weeks of treatment. The body is also adapting to altered neurotransmitter signalling, which is energy-consuming. Some medications have mild cognitive effects directly. The underlying condition itself typically affects cognition, and improvement in thinking can take longer than mood improvement to appear.
What tends to ease and what may persist
Mild early fogginess typically eases by week three. For most patients, cognition returns to baseline or improves as the antidepressant's therapeutic effect emerges — depression and anxiety are both significant cognitive burdens that lift as treatment works. Persistent cognitive impairment past the first month warrants prescriber review. Some patients on long-term treatment report subtle persistent effects, which is an area of ongoing clinical discussion.
What to flag to your prescriber
- Cognitive impairment severe enough to affect work or driving safety.
- Significant memory loss.
- Confusion or disorientation.
- Persistent cognitive symptoms past the first month.
Frequently asked questions
Is brain fog a normal antidepressant side effect?
Mild early cognitive effects are common and usually transient. Severe or persistent cognitive impairment is not typical and warrants medical review.
Will my thinking return to normal?
For most patients yes, often by week three to four. Improvement may continue as the therapeutic effect develops and the cognitive burden of the underlying condition lifts.
Could long-term antidepressants affect my memory?
This is an area of ongoing clinical discussion. If you notice persistent cognitive change after the first month, raise it with your prescriber for individual review.
Evidence and sources referenced
- NICE Guideline NG222 — Depression in adults: treatment and management (United Kingdom).
- Royal Australian and New Zealand College of Psychiatrists (RANZCP) — Clinical Practice Guidelines for Mood Disorders.
- NPS MedicineWise — prescriber and patient resources on antidepressant treatment (Australia).
- Royal College of Psychiatrists — patient information on antidepressants.
- TGA and FDA — product information for SSRI and SNRI medication classes.
- Maudsley Prescribing Guidelines in Psychiatry — prescribing patterns and side-effect timelines.
Related reading
Keep a calmer record of the first 90 days
If you want a calmer way to keep a short daily record across the first 90 days, Causiq is being built for exactly that.
Join the waitlist